Health Canada Pharmacovigilance: Drug Safety & Reporting Rules Explained

What are the legal obligations for pharmaceutical companies operating in Canada? In this video, we break down Health Canada’s strict regulatory requirements for monitoring and reporting drug safety data. Whether you are a regulatory affairs professional, a pharmaceutical manufacturer, or just curious about public health safety, this guide covers everything you need to know about pharmacovigilance compliance in Canada. 📌 What We Cover in This Video: :- The Legal Framework: An overview of Health Canada's mandates for pharmaceutical manufacturers. :- Adverse Reaction Reporting: Rules on tracking and submitting serious adverse drug reactions and unexpected product failures. :- Data Retention Rules: Why companies must maintain comprehensive safety records for 25 years. :- Global & Labeling Updates: Timelines for notifying authorities about foreign regulatory actions and updating warning labels. :- Lifecycle Management: How these protocols protect public health by ensuring long-term drug efficacy and safety. 🔔 Stay Connected! If you found this breakdown helpful, please Like, Subscribe, and hit the Notification Bell for more regulatory insight videos! #HealthCanada #Pharmacovigilance #DrugSafety #PharmaceuticalRegulations #PublicHealth #RegulatoryAffairs #PharmaCompliance